Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases-Reference-Cited by-同舟云学术

Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases

Published:2021 Issue:14 Volume:11 Page:7018-7028
ISSN:1838-7640
Container-title:Theranostics
language:en
Short-container-title:Theranostics

Author:

Wang De-Shen,Yang Hui,Liu Xiao-Yun,Chen Zhi-Gang,Wang Yun,Fong William Pat,Hu Ming-Tao,Zheng Yuan-Chao,Zheng Yun,Li Bin-Kui,Yuan Yun-Fei,Chen Gong,Pan Zhi-Zhong,Song Lele,Li Yu-Hong,Xu Rui-Hua

Publisher

Ivyspring International Publisher

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Medicine (miscellaneous)

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A log odds of positive lymph nodes-based predictive model effectively forecasts prognosis and guides postoperative adjuvant chemotherapy duration in stage III colon cancer: a multi-center retrospective cohort study;BMC Cancer;2024-09-02

2. Comparing Baseline VAF in Circulating tumor DNA and Tumor Tissues Predicting Prognosis of Patients with Colorectal Cancer Liver Metastases After Curative Resection;Clinics and Research in Hepatology and Gastroenterology;2024-09

3. Circulating tumor DNA (ctDNA) application in investigation of cancer: Bench to bedside;Archives of Biochemistry and Biophysics;2024-08

4. Research advances on precision medicine testing in clinical application in colorectal liver metastasis;Chinese Science Bulletin;2024-08-01

5. SULF1 regulates malignant progression of colorectal cancer by modulating ARSH via FAK/PI3K/AKT/mTOR signaling;Cancer Cell International;2024-06-06